nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2D6—Hydroxyurea—head and neck cancer	0.177	0.353	CbGbCtD
Thioridazine—CYP2C8—Fluorouracil—head and neck cancer	0.106	0.211	CbGbCtD
Thioridazine—CYP1A2—Fluorouracil—head and neck cancer	0.0821	0.164	CbGbCtD
Thioridazine—CYP2C9—Fluorouracil—head and neck cancer	0.074	0.147	CbGbCtD
Thioridazine—CYP2D6—Vinblastine—head and neck cancer	0.0627	0.125	CbGbCtD
Thioridazine—HTR7—superior cervical ganglion—head and neck cancer	0.0151	0.212	CbGeAlD
Thioridazine—Ileus paralytic—Vinblastine—head and neck cancer	0.014	0.0599	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00995	0.0427	CcSEcCtD
Thioridazine—Eruption—Hydroxyurea—head and neck cancer	0.00895	0.0384	CcSEcCtD
Thioridazine—Parkinsonism—Fluorouracil—head and neck cancer	0.00872	0.0374	CcSEcCtD
Thioridazine—HRH1—nose—head and neck cancer	0.00813	0.114	CbGeAlD
Thioridazine—Sudden death—Fluorouracil—head and neck cancer	0.00775	0.0333	CcSEcCtD
Thioridazine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00713	0.0306	CcSEcCtD
Thioridazine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00627	0.0269	CcSEcCtD
Thioridazine—HTR7—cranial nerve—head and neck cancer	0.00609	0.0855	CbGeAlD
Thioridazine—HTR2A—trigeminal nerve—head and neck cancer	0.00533	0.0748	CbGeAlD
Thioridazine—Menstruation irregular—Docetaxel—head and neck cancer	0.00517	0.0222	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00517	0.0222	CcSEcCtD
Thioridazine—Eruption—Docetaxel—head and neck cancer	0.00465	0.02	CcSEcCtD
Thioridazine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00392	0.0168	CcSEcCtD
Thioridazine—HTR2A—cranial nerve—head and neck cancer	0.0038	0.0533	CbGeAlD
Thioridazine—Hepatotoxicity—Docetaxel—head and neck cancer	0.00371	0.0159	CcSEcCtD
Thioridazine—Pancytopenia—Vinblastine—head and neck cancer	0.0036	0.0154	CcSEcCtD
Thioridazine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00328	0.0141	CcSEcCtD
Thioridazine—Photosensitivity—Fluorouracil—head and neck cancer	0.00328	0.0141	CcSEcCtD
Thioridazine—Amenorrhoea—Docetaxel—head and neck cancer	0.00326	0.014	CcSEcCtD
Thioridazine—Agranulocytosis—Vinblastine—head and neck cancer	0.00315	0.0135	CcSEcCtD
Thioridazine—Weight increased—Hydroxyurea—head and neck cancer	0.00314	0.0135	CcSEcCtD
Thioridazine—Drowsiness—Hydroxyurea—head and neck cancer	0.00308	0.0132	CcSEcCtD
Thioridazine—Lethargy—Fluorouracil—head and neck cancer	0.00294	0.0126	CcSEcCtD
Thioridazine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00274	0.0117	CcSEcCtD
Thioridazine—Eosinophilia—Fluorouracil—head and neck cancer	0.00246	0.0106	CcSEcCtD
Thioridazine—Anaemia—Vinblastine—head and neck cancer	0.00244	0.0105	CcSEcCtD
Thioridazine—Erythema—Hydroxyurea—head and neck cancer	0.00241	0.0103	CcSEcCtD
Thioridazine—Leukopenia—Vinblastine—head and neck cancer	0.00236	0.0101	CcSEcCtD
Thioridazine—Pancytopenia—Fluorouracil—head and neck cancer	0.00236	0.0101	CcSEcCtD
Thioridazine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00227	0.00974	CcSEcCtD
Thioridazine—Anaemia—Hydroxyurea—head and neck cancer	0.00223	0.00955	CcSEcCtD
Thioridazine—Leukopenia—Hydroxyurea—head and neck cancer	0.00215	0.00925	CcSEcCtD
Thioridazine—Lethargy—Docetaxel—head and neck cancer	0.00212	0.0091	CcSEcCtD
Thioridazine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00211	0.00906	CcSEcCtD
Thioridazine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00207	0.00888	CcSEcCtD
Thioridazine—Anorexia—Vinblastine—head and neck cancer	0.00205	0.00882	CcSEcCtD
Thioridazine—HTR7—mouth—head and neck cancer	0.00205	0.0288	CbGeAlD
Thioridazine—Oedema—Hydroxyurea—head and neck cancer	0.00196	0.00843	CcSEcCtD
Thioridazine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00192	0.00826	CcSEcCtD
Thioridazine—Anorexia—Hydroxyurea—head and neck cancer	0.00187	0.00804	CcSEcCtD
Thioridazine—Decreased appetite—Vinblastine—head and neck cancer	0.00187	0.00804	CcSEcCtD
Thioridazine—Constipation—Vinblastine—head and neck cancer	0.00184	0.00791	CcSEcCtD
Thioridazine—Arrhythmia—Fluorouracil—head and neck cancer	0.00178	0.00763	CcSEcCtD
Thioridazine—Feeling abnormal—Vinblastine—head and neck cancer	0.00178	0.00762	CcSEcCtD
Thioridazine—HTR7—neck—head and neck cancer	0.00175	0.0246	CbGeAlD
Thioridazine—Somnolence—Hydroxyurea—head and neck cancer	0.00175	0.0075	CcSEcCtD
Thioridazine—Erythema—Fluorouracil—head and neck cancer	0.00173	0.00744	CcSEcCtD
Thioridazine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00171	0.00733	CcSEcCtD
Thioridazine—Pancytopenia—Docetaxel—head and neck cancer	0.0017	0.00732	CcSEcCtD
Thioridazine—Constipation—Hydroxyurea—head and neck cancer	0.00168	0.00721	CcSEcCtD
Thioridazine—Weight increased—Docetaxel—head and neck cancer	0.00163	0.00701	CcSEcCtD
Thioridazine—Vision blurred—Fluorouracil—head and neck cancer	0.00163	0.00701	CcSEcCtD
Thioridazine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00162	0.00695	CcSEcCtD
Thioridazine—Anaemia—Fluorouracil—head and neck cancer	0.0016	0.00688	CcSEcCtD
Thioridazine—HTR6—head—head and neck cancer	0.00159	0.0224	CbGeAlD
Thioridazine—Hypersensitivity—Vinblastine—head and neck cancer	0.00159	0.00681	CcSEcCtD
Thioridazine—Jaundice—Docetaxel—head and neck cancer	0.00156	0.0067	CcSEcCtD
Thioridazine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00155	0.00667	CcSEcCtD
Thioridazine—Leukopenia—Fluorouracil—head and neck cancer	0.00155	0.00666	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—head and neck cancer	0.00149	0.00641	CcSEcCtD
Thioridazine—Diarrhoea—Vinblastine—head and neck cancer	0.00147	0.00633	CcSEcCtD
Thioridazine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00145	0.00621	CcSEcCtD
Thioridazine—Confusional state—Fluorouracil—head and neck cancer	0.00143	0.00612	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—head and neck cancer	0.00142	0.00608	CcSEcCtD
Thioridazine—Oedema—Fluorouracil—head and neck cancer	0.00141	0.00607	CcSEcCtD
Thioridazine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00138	0.00594	CcSEcCtD
Thioridazine—Tachycardia—Fluorouracil—head and neck cancer	0.00138	0.00593	CcSEcCtD
Thioridazine—Vomiting—Vinblastine—head and neck cancer	0.00137	0.00588	CcSEcCtD
Thioridazine—Headache—Vinblastine—head and neck cancer	0.00135	0.00579	CcSEcCtD
Thioridazine—Anorexia—Fluorouracil—head and neck cancer	0.00135	0.00579	CcSEcCtD
Thioridazine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00134	0.00577	CcSEcCtD
Thioridazine—Hypotension—Fluorouracil—head and neck cancer	0.00132	0.00567	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—head and neck cancer	0.00128	0.00551	CcSEcCtD
Thioridazine—Nausea—Vinblastine—head and neck cancer	0.00128	0.00549	CcSEcCtD
Thioridazine—ADRA1B—head—head and neck cancer	0.00127	0.0178	CbGeAlD
Thioridazine—Mental disorder—Docetaxel—head and neck cancer	0.00126	0.0054	CcSEcCtD
Thioridazine—Somnolence—Fluorouracil—head and neck cancer	0.00126	0.0054	CcSEcCtD
Thioridazine—HTR7—connective tissue—head and neck cancer	0.00126	0.0176	CbGeAlD
Thioridazine—Erythema—Docetaxel—head and neck cancer	0.00125	0.00537	CcSEcCtD
Thioridazine—Vomiting—Hydroxyurea—head and neck cancer	0.00125	0.00536	CcSEcCtD
Thioridazine—Rash—Hydroxyurea—head and neck cancer	0.00124	0.00532	CcSEcCtD
Thioridazine—Dermatitis—Hydroxyurea—head and neck cancer	0.00124	0.00531	CcSEcCtD
Thioridazine—Headache—Hydroxyurea—head and neck cancer	0.00123	0.00528	CcSEcCtD
Thioridazine—Decreased appetite—Fluorouracil—head and neck cancer	0.00123	0.00528	CcSEcCtD
Thioridazine—HTR7—epithelium—head and neck cancer	0.00119	0.0167	CbGeAlD
Thioridazine—DRD1—head—head and neck cancer	0.00118	0.0166	CbGeAlD
Thioridazine—Nausea—Hydroxyurea—head and neck cancer	0.00117	0.00501	CcSEcCtD
Thioridazine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00117	0.005	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—head and neck cancer	0.00116	0.00496	CcSEcCtD
Thioridazine—ADRA1A—epithelium—head and neck cancer	0.00115	0.0162	CbGeAlD
Thioridazine—Leukopenia—Docetaxel—head and neck cancer	0.00112	0.00481	CcSEcCtD
Thioridazine—Body temperature increased—Fluorouracil—head and neck cancer	0.00112	0.0048	CcSEcCtD
Thioridazine—HTR2A—neck—head and neck cancer	0.00109	0.0153	CbGeAlD
Thioridazine—HTR7—trachea—head and neck cancer	0.00105	0.0148	CbGeAlD
Thioridazine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00104	0.00447	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—head and neck cancer	0.00103	0.00442	CcSEcCtD
Thioridazine—Oedema—Docetaxel—head and neck cancer	0.00102	0.00438	CcSEcCtD
Thioridazine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000999	0.00429	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—head and neck cancer	0.000996	0.00428	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—head and neck cancer	0.000973	0.00418	CcSEcCtD
Thioridazine—Diarrhoea—Fluorouracil—head and neck cancer	0.000968	0.00415	CcSEcCtD
Thioridazine—CHRM2—head—head and neck cancer	0.000955	0.0134	CbGeAlD
Thioridazine—Hypotension—Docetaxel—head and neck cancer	0.000954	0.00409	CcSEcCtD
Thioridazine—HRH1—connective tissue—head and neck cancer	0.000938	0.0132	CbGeAlD
Thioridazine—ADRA2A—connective tissue—head and neck cancer	0.000922	0.0129	CbGeAlD
Thioridazine—HTR2C—head—head and neck cancer	0.00092	0.0129	CbGeAlD
Thioridazine—Somnolence—Docetaxel—head and neck cancer	0.000907	0.0039	CcSEcCtD
Thioridazine—Vomiting—Fluorouracil—head and neck cancer	0.000899	0.00386	CcSEcCtD
Thioridazine—Rash—Fluorouracil—head and neck cancer	0.000892	0.00383	CcSEcCtD
Thioridazine—Dermatitis—Fluorouracil—head and neck cancer	0.000891	0.00382	CcSEcCtD
Thioridazine—HRH1—epithelium—head and neck cancer	0.000891	0.0125	CbGeAlD
Thioridazine—Decreased appetite—Docetaxel—head and neck cancer	0.000887	0.00381	CcSEcCtD
Thioridazine—ADRA1A—lymphoid tissue—head and neck cancer	0.000886	0.0124	CbGeAlD
Thioridazine—Headache—Fluorouracil—head and neck cancer	0.000886	0.0038	CcSEcCtD
Thioridazine—Constipation—Docetaxel—head and neck cancer	0.000873	0.00375	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—head and neck cancer	0.000841	0.00361	CcSEcCtD
Thioridazine—Nausea—Fluorouracil—head and neck cancer	0.00084	0.00361	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—head and neck cancer	0.000807	0.00346	CcSEcCtD
Thioridazine—HRH1—trachea—head and neck cancer	0.000788	0.0111	CbGeAlD
Thioridazine—HTR2A—connective tissue—head and neck cancer	0.000784	0.011	CbGeAlD
Thioridazine—HTR1A—head—head and neck cancer	0.000775	0.0109	CbGeAlD
Thioridazine—ADRA2A—trachea—head and neck cancer	0.000774	0.0109	CbGeAlD
Thioridazine—Hypersensitivity—Docetaxel—head and neck cancer	0.000752	0.00323	CcSEcCtD
Thioridazine—HTR2A—epithelium—head and neck cancer	0.000744	0.0104	CbGeAlD
Thioridazine—HTR7—head—head and neck cancer	0.00074	0.0104	CbGeAlD
Thioridazine—ADRA1A—head—head and neck cancer	0.000714	0.01	CbGeAlD
Thioridazine—DRD2—head—head and neck cancer	0.0007	0.00983	CbGeAlD
Thioridazine—Diarrhoea—Docetaxel—head and neck cancer	0.000698	0.003	CcSEcCtD
Thioridazine—KCNH2—head—head and neck cancer	0.00069	0.00968	CbGeAlD
Thioridazine—CYP1A2—thyroid gland—head and neck cancer	0.000666	0.00934	CbGeAlD
Thioridazine—CYP2E1—lymphoid tissue—head and neck cancer	0.000659	0.00925	CbGeAlD
Thioridazine—HTR2A—trachea—head and neck cancer	0.000658	0.00924	CbGeAlD
Thioridazine—Vomiting—Docetaxel—head and neck cancer	0.000649	0.00279	CcSEcCtD
Thioridazine—Rash—Docetaxel—head and neck cancer	0.000644	0.00276	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—head and neck cancer	0.000643	0.00276	CcSEcCtD
Thioridazine—Headache—Docetaxel—head and neck cancer	0.000639	0.00275	CcSEcCtD
Thioridazine—ADRA2A—thyroid gland—head and neck cancer	0.000612	0.00859	CbGeAlD
Thioridazine—Nausea—Docetaxel—head and neck cancer	0.000606	0.0026	CcSEcCtD
Thioridazine—CYP2E1—thyroid gland—head and neck cancer	0.000599	0.00841	CbGeAlD
Thioridazine—HRH1—head—head and neck cancer	0.000553	0.00776	CbGeAlD
Thioridazine—ADRA2A—head—head and neck cancer	0.000543	0.00762	CbGeAlD
Thioridazine—CYP2E1—head—head and neck cancer	0.000531	0.00746	CbGeAlD
Thioridazine—KCNH2—lymph node—head and neck cancer	0.000483	0.00678	CbGeAlD
Thioridazine—HTR2A—head—head and neck cancer	0.000462	0.00648	CbGeAlD
Thioridazine—CYP2D6—head—head and neck cancer	0.000421	0.0059	CbGeAlD
Thioridazine—HRH1—lymph node—head and neck cancer	0.000387	0.00543	CbGeAlD
Thioridazine—ADRA2A—lymph node—head and neck cancer	0.00038	0.00534	CbGeAlD
Thioridazine—CYP2C19—Metabolism—GPX1—head and neck cancer	3.64e-05	0.000187	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HRAS—head and neck cancer	3.6e-05	0.000186	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.6e-05	0.000185	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	3.56e-05	0.000183	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—TYMS—head and neck cancer	3.54e-05	0.000182	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	3.51e-05	0.000181	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	3.51e-05	0.000181	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—TYMS—head and neck cancer	3.51e-05	0.00018	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—AKT1—head and neck cancer	3.5e-05	0.00018	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	3.5e-05	0.00018	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.49e-05	0.00018	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL2—head and neck cancer	3.47e-05	0.000179	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.46e-05	0.000178	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—MAPK3—head and neck cancer	3.44e-05	0.000177	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	3.43e-05	0.000177	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—VEGFA—head and neck cancer	3.42e-05	0.000176	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—VEGFA—head and neck cancer	3.42e-05	0.000176	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	3.41e-05	0.000175	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	3.39e-05	0.000175	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—STAT3—head and neck cancer	3.39e-05	0.000175	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—EGFR—head and neck cancer	3.39e-05	0.000175	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—STAT3—head and neck cancer	3.39e-05	0.000174	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CCND1—head and neck cancer	3.38e-05	0.000174	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	3.35e-05	0.000173	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—GPX1—head and neck cancer	3.35e-05	0.000172	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	3.34e-05	0.000172	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	3.33e-05	0.000172	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	3.33e-05	0.000172	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	3.33e-05	0.000171	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—EGFR—head and neck cancer	3.33e-05	0.000171	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—GPX1—head and neck cancer	3.32e-05	0.000171	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.32e-05	0.000171	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.31e-05	0.000171	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	3.28e-05	0.000169	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—MAPK1—head and neck cancer	3.27e-05	0.000169	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—EGFR—head and neck cancer	3.27e-05	0.000169	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.27e-05	0.000168	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	3.27e-05	0.000168	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	3.27e-05	0.000168	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PTEN—head and neck cancer	3.26e-05	0.000168	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.24e-05	0.000167	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MAPK3—head and neck cancer	3.24e-05	0.000167	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MAPK3—head and neck cancer	3.23e-05	0.000167	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	3.19e-05	0.000164	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	3.19e-05	0.000164	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.19e-05	0.000164	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—AKT1—head and neck cancer	3.18e-05	0.000164	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	3.18e-05	0.000164	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.13e-05	0.000161	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.12e-05	0.000161	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	3.1e-05	0.00016	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	3.08e-05	0.000159	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—MAPK1—head and neck cancer	3.08e-05	0.000159	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EGFR—head and neck cancer	3.08e-05	0.000159	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—MAPK1—head and neck cancer	3.08e-05	0.000158	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EGFR—head and neck cancer	3.08e-05	0.000158	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	3.03e-05	0.000156	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	3.03e-05	0.000156	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTGS2—head and neck cancer	3.02e-05	0.000156	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	3.01e-05	0.000155	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	3e-05	0.000154	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—TYMS—head and neck cancer	3e-05	0.000154	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL2—head and neck cancer	2.98e-05	0.000154	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL2—head and neck cancer	2.97e-05	0.000153	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.96e-05	0.000152	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.96e-05	0.000152	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	2.95e-05	0.000152	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—VEGFA—head and neck cancer	2.95e-05	0.000152	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	2.94e-05	0.000151	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—STAT3—head and neck cancer	2.92e-05	0.00015	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CCND1—head and neck cancer	2.91e-05	0.00015	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	2.9e-05	0.000149	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	2.89e-05	0.000149	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CCND1—head and neck cancer	2.89e-05	0.000149	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	2.89e-05	0.000149	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	2.87e-05	0.000148	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	2.84e-05	0.000146	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	2.84e-05	0.000146	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—GPX1—head and neck cancer	2.84e-05	0.000146	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	2.83e-05	0.000146	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.81e-05	0.000145	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PTEN—head and neck cancer	2.81e-05	0.000144	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PTEN—head and neck cancer	2.79e-05	0.000144	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK3—head and neck cancer	2.79e-05	0.000144	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTGS2—head and neck cancer	2.78e-05	0.000143	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	2.77e-05	0.000143	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	2.74e-05	0.000141	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	2.72e-05	0.00014	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	2.72e-05	0.00014	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.7e-05	0.000139	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	2.68e-05	0.000138	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	2.67e-05	0.000138	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	2.67e-05	0.000138	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	2.67e-05	0.000138	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	2.67e-05	0.000138	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—MAPK1—head and neck cancer	2.65e-05	0.000137	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EGFR—head and neck cancer	2.65e-05	0.000137	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	2.65e-05	0.000136	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PTEN—head and neck cancer	2.64e-05	0.000136	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	2.63e-05	0.000136	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	2.63e-05	0.000135	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	2.62e-05	0.000135	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—head and neck cancer	2.62e-05	0.000135	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	2.61e-05	0.000134	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	2.6e-05	0.000134	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	2.6e-05	0.000134	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—head and neck cancer	2.59e-05	0.000133	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—head and neck cancer	2.58e-05	0.000133	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—head and neck cancer	2.58e-05	0.000133	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—head and neck cancer	2.57e-05	0.000132	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	2.56e-05	0.000132	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—head and neck cancer	2.55e-05	0.000131	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	2.55e-05	0.000131	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	2.53e-05	0.00013	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—head and neck cancer	2.53e-05	0.00013	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	2.52e-05	0.00013	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	2.52e-05	0.00013	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	2.51e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—head and neck cancer	2.51e-05	0.000129	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—head and neck cancer	2.51e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—head and neck cancer	2.5e-05	0.000129	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—head and neck cancer	2.47e-05	0.000127	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—head and neck cancer	2.47e-05	0.000127	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	2.47e-05	0.000127	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—head and neck cancer	2.46e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	2.46e-05	0.000127	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	2.44e-05	0.000125	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	2.42e-05	0.000125	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—head and neck cancer	2.42e-05	0.000125	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—head and neck cancer	2.42e-05	0.000125	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	2.41e-05	0.000124	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	2.4e-05	0.000124	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.4e-05	0.000124	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	2.4e-05	0.000123	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	2.39e-05	0.000123	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	2.38e-05	0.000123	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	2.38e-05	0.000123	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	2.37e-05	0.000122	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	2.37e-05	0.000122	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	2.36e-05	0.000122	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	2.36e-05	0.000121	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	2.34e-05	0.000121	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	2.32e-05	0.00012	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	2.32e-05	0.000119	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.31e-05	0.000119	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	2.3e-05	0.000119	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	2.28e-05	0.000118	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	2.28e-05	0.000118	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	2.28e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—head and neck cancer	2.28e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	2.27e-05	0.000117	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—head and neck cancer	2.27e-05	0.000117	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—head and neck cancer	2.23e-05	0.000115	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	2.22e-05	0.000115	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	2.2e-05	0.000114	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—head and neck cancer	2.2e-05	0.000113	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	2.19e-05	0.000113	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	2.18e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—head and neck cancer	2.18e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—head and neck cancer	2.18e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	2.17e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	2.17e-05	0.000112	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	2.17e-05	0.000112	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—head and neck cancer	2.16e-05	0.000111	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	2.15e-05	0.000111	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	2.15e-05	0.000111	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	2.14e-05	0.00011	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.14e-05	0.00011	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—head and neck cancer	2.13e-05	0.00011	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	2.13e-05	0.00011	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	2.12e-05	0.000109	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	2.1e-05	0.000108	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—head and neck cancer	2.09e-05	0.000108	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	2.07e-05	0.000107	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	2.07e-05	0.000106	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	2.03e-05	0.000105	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	2.03e-05	0.000104	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	2e-05	0.000103	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—head and neck cancer	2e-05	0.000103	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	1.99e-05	0.000103	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	1.98e-05	0.000102	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	1.97e-05	0.000102	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—head and neck cancer	1.97e-05	0.000101	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.95e-05	0.000101	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	1.93e-05	9.96e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	1.93e-05	9.96e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.93e-05	9.94e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.93e-05	9.93e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—head and neck cancer	1.91e-05	9.86e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.9e-05	9.81e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.88e-05	9.71e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	1.88e-05	9.7e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—head and neck cancer	1.88e-05	9.68e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.87e-05	9.62e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	1.86e-05	9.58e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—head and neck cancer	1.83e-05	9.43e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.82e-05	9.39e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—head and neck cancer	1.82e-05	9.38e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	1.79e-05	9.23e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	1.79e-05	9.23e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.74e-05	8.98e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.74e-05	8.95e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.72e-05	8.85e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.71e-05	8.8e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.71e-05	8.8e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	1.71e-05	8.79e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.7e-05	8.77e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.68e-05	8.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	1.68e-05	8.64e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.67e-05	8.62e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.67e-05	8.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—head and neck cancer	1.65e-05	8.52e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—head and neck cancer	1.65e-05	8.5e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—head and neck cancer	1.62e-05	8.36e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.62e-05	8.34e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—head and neck cancer	1.62e-05	8.33e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—head and neck cancer	1.61e-05	8.28e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.61e-05	8.28e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	1.58e-05	8.15e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—head and neck cancer	1.58e-05	8.13e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	1.56e-05	8.01e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	1.55e-05	8e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.55e-05	7.98e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.54e-05	7.93e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—head and neck cancer	1.52e-05	7.83e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	1.5e-05	7.75e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.48e-05	7.6e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.46e-05	7.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	1.44e-05	7.41e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—head and neck cancer	1.42e-05	7.31e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	1.4e-05	7.19e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—head and neck cancer	1.4e-05	7.19e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—head and neck cancer	1.39e-05	7.18e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	1.37e-05	7.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	1.37e-05	7.04e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.32e-05	6.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	1.27e-05	6.54e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.21e-05	6.24e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—head and neck cancer	1.21e-05	6.21e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.2e-05	6.19e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—head and neck cancer	1.08e-05	5.54e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.03e-05	5.29e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—head and neck cancer	9.9e-06	5.1e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—head and neck cancer	9.82e-06	5.06e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—head and neck cancer	8.39e-06	4.32e-05	CbGpPWpGaD
